Weight loss drugs may also slow down aging: Research

 

Weight loss drugs may also slow down aging: Research

A new study has revealed that the popular weight loss drug Ozempic and other GLP-1 drugs may also slow down the rate of physical or biological aging.

According to research published by the University of California San Diego, GLP-1 drugs based on semaglutide are likely reprogramming the body's cells, making the immune system more effective and reducing inflammation in the body. As a result, the body's decline or aging process may slow down at the cellular level.

Several medical benefits of GLP-1 drugs have been revealed before, and the San Diego research team believes that these benefits may be linked to a decrease in the rate of biological aging.

However, the researchers have clarified that more research is still needed to understand the whole process.

Professor Michael Corley, who led the study, said scientists are not saying that semaglutide can reverse aging or make people younger, but the team is finding evidence that it can slow down some of the biological processes associated with aging.

About 30 million Americans are currently taking GLP-1 drugs. These drugs are used not only for weight loss but also to treat other medical conditions, including type 2 diabetes and heart disease.